Jyoti Resins and Adhesives Ltd
JYOTIRESJyoti Resins and Adhesives Ltd is cheap for a reason. The P/E sits at the 21st percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved −5.3% against a −31.6% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (51 weeks in) while the P/E sits at the 21st percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −29.4% year on year, and 43% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Jyoti Resins and Adhesives Ltd trades at ₹869, in a downtrend and 51 weeks into that stage. That is −10.5% against its own 200-day average. It sits at 6% of a 52-week range of ₹831 to ₹1,453. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 3 straight weeks.
Today the stock is in a downtrend — week 51 of stage 4, confirmed. At ₹869 it trades −10.5% versus its 200-day average and sits at 6% of its 52-week range (₹831–₹1,453).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +2,729% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Jyoti Resins and Adhesives Ltd trades at 16.2× P/E, near the bottom of its own range — cheaper only 21% of the time. Its long-run median P/E is 23.9×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 16.2× is near the bottom of its own range — cheaper only 21% of the time, against a long-run median of 23.9× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −5.3% against a −31.6% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +25.4%/yr price move, ~+34.4%/yr came from earnings growth and ~−9.0 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Jyoti Resins and Adhesives Ltd was paying for profit growth of about 5.5% a year. Today the market pays 16.2× P/E, the 21st percentile of its own 11-year range.
What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is the whole of what a buyer is backing.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Jyoti Resins and Adhesives Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −11.1% latest against +16.7% at its 12-quarter best), ROCE slipping at 36.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +10.9% | +6.5% | +25.5% | +21.2% |
| Profit | −5.4% | +15.0% | +42.3% | — |
| EPS | −5.3% | +14.6% | +41.9% | +78.3% |
| Share price | −31.6% | −20.1% | +25.4% | +40.7% |
4-Factor Sector Score
43.1/100 — rank 13 of 20 in Chemicals - Organic · 69% evidence confidence
Jyoti Resins and Adhesives Ltd scores 43.1 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 13. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 9.7 + 19.2 + 10.8 + 3.4 = 43.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Jyoti Resins and Adhesives Ltd reported ₹88.0 Cr of revenue in the Jun 26 quarter, +17.3% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 21.2% a year. The last full year, FY26, came in at ₹315 Cr. The last four reported quarters add to ₹327 Cr.
FY26 revenue came in at ₹315 Cr (+10.9% on the year), capping 10 years at 21.2% compound. The latest quarter (Jun 26) printed ₹88.0 Cr, +17.3% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +12.6% growth against the decade's 21.2% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +12.8% over the last 4 quarters against +11.1%/yr over the last 8 — stabilising; TTM profit −11.1% vs −4.4%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Jyoti Resins and Adhesives Ltd's operating margin is 14.0% in the Jun 26 quarter, −13.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.7% to 33.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 14.0%, −13.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.7%–33.0%.
🚨 Why the margin moved: operating margin went −13.1 pp year on year while gross margin went −13.4 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Jyoti Resins and Adhesives Ltd earned ₹12.0 Cr of net profit in the Jun 26 quarter, −29.4% year on year. Full-year FY26 profit was ₹70.0 Cr. That is 13.6% of the quarter's revenue. The same quarter a year earlier earned ₹17.0 Cr.
Jun 26 profit was ₹12.0 Cr, −29.4% year on year. On the full year, FY26 printed ₹70.0 Cr (−5.4%).
🚨 Why profit moved: revenue contributed +17.3% and the margin −13.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −11.1% vs revenue +12.6%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 43% of Jyoti Resins and Adhesives Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹48.0 Cr of operating cash against ₹70.0 Cr of profit. After ₹4.0 Cr of capital spending, ₹44.0 Cr was left as free cash.
FY26: operating cash of ₹48.0 Cr against reported profit of ₹70.0 Cr, leaving free cash of ₹44.0 Cr after ₹4.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 43% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 43%: the cash cycle tightened 34 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: the bigger cash user is investment — capital spending ran 1.6× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Jyoti Resins and Adhesives Ltd's cash conversion cycle runs 180 days in FY26, down from 214 days in FY21. Capital spending ran ₹8.0 Cr over the last 3 years. At FY26 sales of ₹315 Cr each day of that cycle holds about ₹0.9 Cr, so roughly ₹155 Cr sits inside the business at any moment.
FY26: debtors at 185 days, inventory at 39 days — roughly 1.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 180 days, tighter than FY21's 214.
The full loop: cash goes out to suppliers and production on day 0; stock waits 39 days to sell; customers pay about 185 days after that; and suppliers themselves are paid at 44 days — netting out to the 180-day cycle.
In money terms: at FY26 sales of ₹315 Cr, each day of the cycle holds about ₹0.9 Cr — so the 180-day loop keeps roughly ₹155 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹8.0 Cr over the last 3 fiscal years against ₹5.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Jyoti Resins and Adhesives Ltd earns a ROCE of 36% in FY26. That is up from a trough of 7% in FY15. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 22.2% net margin on 0.74× asset turns.
FY26 ROCE is 36%, recovered from a FY15 trough of 7% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 22.2% net margin × 0.74× asset turns × 1.47× balance-sheet leverage ≈ 24.1% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Jyoti Resins and Adhesives Ltd carries ₹0.0 Cr of borrowings against ₹289 Cr of equity in FY26, a debt-to-equity of 0.00. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr. Capital spending ran ₹8.0 Cr across the last 3 of those years.
FY26: borrowings of ₹0.0 Cr against equity of ₹289 Cr — a debt-to-equity of 0.00. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr while capital spending ran ₹8.0 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 3.5 points of Jyoti Resins and Adhesives Ltd over 8 quarters, the biggest move on the register. That takes promoters to 54.4% of the company. Foreign institutions moved −0.3 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +3.5 points over 8 quarters to 54.4%; Foreign institutions: −0.3 points over 8 quarters to 0.1%; Domestic institutions: +0.0 points over 8 quarters to 0.1%.
Why the register moved: promoters drove it (+3.5 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Jyoti Resins and Adhesives Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Valiant Organics LtdVALIANTORG | 63.2/100Mixed-positive evidence87% evidence | TURNING | 24.4/35 Revenue 1.5% · PAT 100% · OPM change 6 pp 95% evidence | 10.8/25 ROCE 5.5% · OPM 18% 95% evidence | 11.0/20 P/E 22× · PEG — 50% evidence | 17.0/20 RS sector 9.4% · RS bench 42.8% · 1Y 9.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 10.8 + 11 + 17 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Foseco India LtdFOSECOIND | 63.1/100Mixed-positive evidence87% evidence | BREAKING OUT | 19.5/35 Revenue 32.6% · PAT 20.5% · OPM change 5.2 pp 100% evidence | 16.9/25 ROCE 17.4% · OPM 23% 100% evidence | 11.5/20 P/E 44.8× · PEG 1.31 65% evidence | 15.2/20 RS sector 24.1% · RS bench 21% · 1Y -4%6 of 10 weeks ahead 70% evidence |
| Exact sum: 19.5 + 16.9 + 11.5 + 15.2 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Elantas Beck India LtdELANTAS | 62.3/100Mixed-positive evidence76% evidence | BREAKING OUT | 26.3/35 Revenue 17.6% · PAT 33.1% · OPM change 10 pp 95% evidence | 19.1/25 ROCE 21.2% · OPM 29% 76% evidence | 6.3/20 P/E 64.8× · PEG — 50% evidence | 10.6/20 RS sector -6.6% · RS bench 52.4% · 1Y 35.2%6 of 9 weeks ahead 70% evidence |
| Exact sum: 26.3 + 19.1 + 6.3 + 10.6 = 62.3 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 4OCCL LtdOCCLLTD | 61.4/100Mixed-positive evidence60% evidence | BREAKING OUT | 26.5/35 Revenue 40.6% · PAT 100% · OPM change 7 pp 95% evidence | 12.2/25 ROCE 13% · OPM 28% 76% evidence | 11.5/20 P/E 10.4× · PEG — 15% evidence | 11.2/20 RS sector — · RS bench 41.5% · 1Y —9 of 9 weeks ahead 25% evidence |
| Exact sum: 26.5 + 12.2 + 11.5 + 11.2 = 61.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Shri Ahimsa Naturals LtdSHRIAHIMSA | 61.0/100Thin evidence · provisional56% evidence | LEADER | 18.9/35 Revenue — · PAT — · OPM change -2 pp 26% evidence | 18.0/25 ROCE 21.7% · OPM 28% 95% evidence | 10.0/20 P/E 37.2× · PEG — 15% evidence | 14.1/20 RS sector 22.9% · RS bench 58.3% · 1Y 113%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 18 + 10 + 14.1 = 61 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Indo Amines LtdINDOAMIN | 60.6/100Mixed-positive evidence81% evidence | BASING | 22.3/35 Revenue 13.3% · PAT 24.2% · OPM change 3 pp 95% evidence | 16.8/25 ROCE 19.9% · OPM 14% 95% evidence | 14.0/20 P/E 11.3× · PEG — 50% evidence | 7.5/20 RS sector -11.9% · RS bench 4.6% · 1Y -12.6%4 of 10 weeks ahead 70% evidence |
| Exact sum: 22.3 + 16.8 + 14 + 7.5 = 60.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Balaji Amines LtdBALAMINES | 59.3/100Mixed-positive evidence82% evidence | LEADER | 26.4/35 Revenue 11.1% · PAT 41.6% · OPM change 10 pp 95% evidence | 13.3/25 ROCE 11% · OPM 25% 76% evidence | 7.0/20 P/E 36.1× · PEG — 50% evidence | 12.6/20 RS sector 18.3% · RS bench 51.3% · 1Y 53.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.4 + 13.3 + 7 + 12.6 = 59.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Nitta Gelatin India LtdNITTAGELA | 59.2/100Mixed-positive evidence72% evidence | TURNING | 18.8/35 Revenue 10.5% · PAT 24.1% · OPM change 4 pp 95% evidence | 19.1/25 ROCE 27.7% · OPM 24% 95% evidence | 9.7/20 P/E 14.4× · PEG — 50% evidence | 11.6/20 RS sector — · RS bench 46.7% · 1Y —7 of 9 weeks ahead 25% evidence |
| Exact sum: 18.8 + 19.1 + 9.7 + 11.6 = 59.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9BASF India LtdBASF | 52.7/100Mixed-positive evidence94% evidence | BREAKING OUT | 20.0/35 Revenue 6.5% · PAT 62.4% · OPM change 4 pp 100% evidence | 10.7/25 ROCE 14.5% · OPM 10% 100% evidence | 14.3/20 P/E 25.7× · PEG 1.62 100% evidence | 7.7/20 RS sector -3.3% · RS bench -3.4% · 1Y -21.2%4 of 11 weeks ahead 70% evidence |
| Exact sum: 20 + 10.7 + 14.3 + 7.7 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10GFL LtdGFLLIMITED | 51.5/100Mixed-positive evidence72% evidence | BREAKING OUT | 23.9/35 Revenue 10.5% · PAT 100% · OPM change 1064 pp 71% evidence | 7.8/25 ROCE 2.1% · OPM 28.2% 95% evidence | 11.3/20 P/E 10.6× · PEG — 15% evidence | 8.5/20 RS sector -14% · RS bench 12.9% · 1Y -2.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 23.9 + 7.8 + 11.3 + 8.5 = 51.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Laxmi Organic Industries LtdLXCHEM | 49.5/100Mixed-negative evidence94% evidence | BREAKING OUT | 19.9/35 Revenue 5.5% · PAT 26% · OPM change 7.6 pp 100% evidence | 8.4/25 ROCE 4.7% · OPM 12% 100% evidence | 14.7/20 P/E 38.8× · PEG 1.14 100% evidence | 6.5/20 RS sector -19.5% · RS bench 9.7% · 1Y -16.6%9 of 10 weeks ahead 70% evidence |
| Exact sum: 19.9 + 8.4 + 14.7 + 6.5 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Fine Organic Industries LtdFINEORG | 45.6/100Mixed-negative evidence100% evidence | BREAKING OUT | 14.8/35 Revenue 7.1% · PAT 5.8% · OPM change 4 pp 100% evidence | 17.6/25 ROCE 21.5% · OPM 25% 100% evidence | 7.2/20 P/E 36.2× · PEG 2.7 100% evidence | 6.0/20 RS sector -13.8% · RS bench 12.9% · 1Y 7.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 17.6 + 7.2 + 6 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Jyoti Resins and Adhesives Ltdthis pageJYOTIRES | 43.1/100Mixed-negative evidence69% evidence | 9.7/35 Revenue 12.8% · PAT -11.1% · OPM change -13 pp 95% evidence | 19.2/25 ROCE 36.5% · OPM 14% 76% evidence | 10.8/20 P/E 16.2× · PEG — 15% evidence | 3.4/20 RS sector -19.8% · RS bench -11.8% · 1Y -31.4%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 9.7 + 19.2 + 10.8 + 3.4 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Sigachi Industries LtdSIGACHI | 41.5/100Mixed-negative evidence79% evidence | BREAKING OUT | 9.0/35 Revenue -9.6% · PAT 100% · OPM change -5.2 pp 71% evidence | 7.2/25 ROCE 6.2% · OPM 13.6% 95% evidence | 8.4/20 P/E 64.5× · PEG — 50% evidence | 16.9/20 RS sector 6.2% · RS bench 38.7% · 1Y 20.6%11 of 12 weeks ahead 100% evidence |
| Exact sum: 9 + 7.2 + 8.4 + 16.9 = 41.5 · Decision use: Price leads the evidence: RS versus the benchmark is 38.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Shree Ganesh Remedies LtdSGRL | 41.1/100Mixed-negative evidence76% evidence | 6.6/35 Revenue -8.8% · PAT -29.4% · OPM change -6.3 pp 95% evidence | 14.6/25 ROCE 14.1% · OPM 23.3% 76% evidence | 7.1/20 P/E 54.8× · PEG — 50% evidence | 12.8/20 RS sector 3.3% · RS bench 25.3% · 1Y 15.5%4 of 12 weeks ahead 70% evidence | |
| Exact sum: 6.6 + 14.6 + 7.1 + 12.8 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Oriental Aromatics LtdOAL | 36.0/100Mixed-negative evidence74% evidence | BREAKING OUT | 12.5/35 Revenue 13.5% · PAT -77.7% · OPM change -0.4 pp 95% evidence | 4.3/25 ROCE 4.5% · OPM 7.6% 95% evidence | 8.7/20 P/E 337× · PEG — 15% evidence | 10.5/20 RS sector -8.7% · RS bench 66.9% · 1Y 57.7%10 of 10 weeks ahead 70% evidence |
| Exact sum: 12.5 + 4.3 + 8.7 + 10.5 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Fairchem Organics LtdFAIRCHEMOR | 33.6/100Adverse evidence87% evidence | BREAKING OUT | 17.1/35 Revenue 0% · PAT 50% · OPM change 6 pp 95% evidence | 6.0/25 ROCE 3.3% · OPM 10% 95% evidence | 8.0/20 P/E 52× · PEG — 50% evidence | 2.5/20 RS sector -26.6% · RS bench -3.9% · 1Y -22.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 6 + 8 + 2.5 = 33.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Gem Aromatics LtdGEMAROMA | 24.4/100Adverse evidence65% evidence | ASLEEP | 1.8/35 Revenue -24.3% · PAT -80% · OPM change -13.6 pp 95% evidence | 6.4/25 ROCE 3.4% · OPM 3.3% 95% evidence | 8.5/20 P/E 772.2× · PEG — 15% evidence | 7.7/20 RS sector — · RS bench -10.4% · 1Y -39.3%5 of 10 weeks ahead 25% evidence |
| Exact sum: 1.8 + 6.4 + 8.5 + 7.7 = 24.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Sacheerome LtdSACHEEROME | 59.1/100Thin evidence · provisional41% evidence | BREAKING OUT | 17.3/35 Revenue — · PAT — · OPM change 1 pp 26% evidence | 20.3/25 ROCE 35.7% · OPM 23% 95% evidence | 9.7/20 P/E 40.1× · PEG — 15% evidence | 11.8/20 RS sector — · RS bench 46.9% · 1Y 155.5%9 of 10 weeks ahead 25% evidence |
| Exact sum: 17.3 + 20.3 + 9.7 + 11.8 = 59.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Citurgia Biochemicals LtdCITURGIA | 36.7/100Thin evidence · provisional27% evidence | 11.8/35 Revenue — · PAT -68.2% · OPM change — 33% evidence | 4.9/25 ROCE -2150% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 11.8 + 4.9 + 10 + 10 = 36.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Jyoti Resins and Adhesives Ltd's share price today?
Jyoti Resins and Adhesives Ltd trades at ₹869, −31.6% over the past year. The company is valued at ₹1,041 Cr. The stock sits at 6% of its 52-week range of ₹831–₹1,453, −10.5% versus its 200-day average. On the tape, the price is in a downtrend, 51 weeks in. — as of 11 September 2026.
What were Jyoti Resins and Adhesives Ltd's latest quarterly results?
Jyoti Resins and Adhesives Ltd reported revenue of ₹88.0 Cr and net profit of ₹12.0 Cr for the Jun 26 quarter. Revenue rose 17.3% and profit fell 29.4% year on year. Earnings per share were ₹9.79. The operating margin was 14.0%, 13.0 pp lower than a year earlier. — as of 11 September 2026.
What is Jyoti Resins and Adhesives Ltd's revenue?
Jyoti Resins and Adhesives Ltd reported revenue of ₹88.0 Cr in the Jun 26 quarter, +17.3% year on year. For the full FY26 fiscal year, revenue was ₹315 Cr (+10.9%). Over the last 10 years revenue compounded at 21.2% a year. — as of 11 September 2026.
What is Jyoti Resins and Adhesives Ltd's profit?
Jyoti Resins and Adhesives Ltd earned ₹12.0 Cr of net profit in the Jun 26 quarter, −29.4% year on year. Full-year FY26 profit was ₹70.0 Cr. The operating margin ran 14.0% in the latest quarter. — as of 11 September 2026.
What is Jyoti Resins and Adhesives Ltd's market cap?
Jyoti Resins and Adhesives Ltd's market capitalisation is ₹1,041 Cr at a share price of ₹869. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Jyoti Resins and Adhesives Ltd's P/E ratio?
Jyoti Resins and Adhesives Ltd trades at a P/E of 16.2×, at the 21st percentile of its own 11-year range, against a long-run median of 23.9×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Jyoti Resins and Adhesives Ltd pay a dividend?
Yes — Jyoti Resins and Adhesives Ltd's dividend payout was 15% of profit in FY26, and it recorded a payout in 7 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Jyoti Resins and Adhesives Ltd overvalued?
On its own history, Jyoti Resins and Adhesives Ltd looks cheap: its P/E of 16.2× has been cheaper only 21% of the time in 11 years (long-run median 23.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Jyoti Resins and Adhesives Ltd growing?
Not right now — Jyoti Resins and Adhesives Ltd's latest numbers are shrinking: latest-quarter revenue +17.3% year on year, profit −29.4%, and the margin −13.0 pp at 14.0%. The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Jyoti Resins and Adhesives Ltd performing?
Jyoti Resins and Adhesives Ltd is in a downtrend, 51 weeks in. Its latest quarter's revenue rose 17.3% and profit fell 29.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Jyoti Resins and Adhesives Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −11.1% latest against +16.7% at its 12-quarter best), ROCE slipping at 36.0%. The read comes from the last 12 quarters of growth (revenue growth +12.8% latest, profit growth −11.1% latest, eps growth −11.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Jyoti Resins and Adhesives Ltd in an uptrend?
No — the price is in a downtrend (week 51 of stage 4), trading −10.5% versus its 200-day average and at 6% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Jyoti Resins and Adhesives Ltd beating the market?
On recent form, yes — Jyoti Resins and Adhesives Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 3 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +2,729% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will Jyoti Resins and Adhesives Ltd's share price go up?
This page publishes no price forecast for Jyoti Resins and Adhesives Ltd. What it measures instead: the share price is ₹869, the price is in a downtrend 51 weeks in. Its P/E of 16.2× sits at the 21st percentile of its own 11-year range. — as of 11 September 2026.
Who owns Jyoti Resins and Adhesives Ltd?
Promoters hold 54.4% of Jyoti Resins and Adhesives Ltd, foreign institutions 0.1%, domestic institutions 0.1% and the public 45.5% (latest quarter). The biggest move on the register over the last two years: Promoters added 3.5 points over 8 quarters. — as of 11 September 2026.
Does Jyoti Resins and Adhesives Ltd have too much debt?
No — Jyoti Resins and Adhesives Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill 1×. FY26 borrowings were ₹0.0 Cr against equity of ₹289 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is Jyoti Resins and Adhesives Ltd's capex?
Jyoti Resins and Adhesives Ltd spent ₹8.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹4.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Jyoti Resins and Adhesives Ltd's cash flow?
Jyoti Resins and Adhesives Ltd generated ₹48.0 Cr of operating cash flow in FY26 and ₹44.0 Cr of free cash flow after ₹4.0 Cr of capital spending. Reported profit that year was ₹70.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Jyoti Resins and Adhesives Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 43% of Jyoti Resins and Adhesives Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹48.0 Cr against reported profit of ₹70.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Jyoti Resins and Adhesives Ltd in its business cycle?
Jyoti Resins and Adhesives Ltd's FY26 operating margin was 27.0%, against a 13-year band of 2.7%–33.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 14.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Jyoti Resins and Adhesives Ltd's price assume?
At its price on 13 June 2026, Jyoti Resins and Adhesives Ltd was priced for profit growth of about 5.5% a year. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Jyoti Resins and Adhesives Ltd story?
The sharpest disagreement: annual EPS moved −5.3% against a −31.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Jyoti Resins and Adhesives Ltd a stock worth studying right now?
This is not investment advice. The machine read: Jyoti Resins and Adhesives Ltd is cheap for a reason. The P/E sits at the 21st percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!